Histone modification in podocyte injury of diabetic nephropathy

J Mol Med (Berl). 2022 Oct;100(10):1373-1386. doi: 10.1007/s00109-022-02247-7. Epub 2022 Aug 30.

Abstract

Diabetic nephropathy (DN), an important complication of diabetic microvascular disease, is one of the leading causes of end-stage renal disease (ESRD), which brings heavy burdens to the whole society. Podocytes are terminally differentiated glomerular cells, which act as a pivotal component of glomerular filtration barrier. When podocytes are injured, glomerular filtration barrier is damaged, and proteinuria would occur. Dysfunction of podocytes contributes to DN. And degrees of podocyte injury influence prognosis of DN. Growing evidences have shown that epigenetics does a lot in the evolvement of podocyte injury. Epigenetics includes DNA methylation, histone modification, and non-coding RNA. Among them, histone modification plays an indelible role. Histone modification includes histone methylation, histone acetylation, and other modifications such as histone phosphorylation, histone ubiquitination, histone ADP-ribosylation, histone crotonylation, and histone β-hydroxybutyrylation. It can affect chromatin structure and regulate gene transcription to exert its function. This review is to summarize documents about pathogenesis of podocyte injury, most importantly, histone modification of podocyte injury in DN recently to provide new ideas for further molecular research, diagnosis, and treatment.

Keywords: Diabetic nephropathy; Histone acetylation; Histone methylation; Histone modification; Podocyte.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus* / pathology
  • Diabetic Nephropathies* / etiology
  • Diabetic Nephropathies* / pathology
  • Histone Code
  • Histones / metabolism
  • Humans
  • Podocytes* / metabolism
  • Proteinuria / pathology

Substances

  • Histones